Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer neuroscience / / Moran Amit and Nicole N. Scheff, editors
| Cancer neuroscience / / Moran Amit and Nicole N. Scheff, editors |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (205 pages) |
| Disciplina | 616.9948 |
| Soggetto topico |
Nervous system - Cancer
Neurosciences |
| ISBN | 3-031-32429-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction -- Chapter 2. Neuronal influence on cancer initiation and growth -- Chapter 2.1 Paracrine signaling in CNS primary tumors and brain metastases -- Chapter 2.2 Paracrine signaling in PNS primary tumors -- Chapter 3. Neuronal influence on cancer invasion and metastasis including perineurial invasion -- Chapter 4. Neurotrophic activity of tumors -- Chapter 5. Cancer interactions with Schwann cells -- Chapter 6. Cancer-glial interactions -- Chapter 7. Neuron-cancer synaptic and other electrical signaling -- Chapter 8. Neuro-immune interactions system and immuno-oncology -- Chapter 9. Nervous system interactions with non-immune elements in the cancer microenvironment -- Chapter 10. Cancer-induced remodeling of the nervous system -- Chapter 11. Cancer and pain -- Chapter 12. Systemic interactions of cancer and the impact on the nervous system -- Chapter 13. Tools and model systems to study nerve-cancer interactions -- Chapter 14. Conclusions and Future Directions. |
| Record Nr. | UNINA-9910736012903321 |
| Cham, Switzerland : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Central Nervous System Metastases / / edited by Manmeet Ahluwalia, Philippe Metellus, Riccardo Soffietti
| Central Nervous System Metastases / / edited by Manmeet Ahluwalia, Philippe Metellus, Riccardo Soffietti |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XIII, 421 p. 45 illus., 37 illus. in color.) |
| Disciplina |
617.48
616.9948 |
| Soggetto topico |
Neurosurgery
Radiotherapy Oncology Cancer research Quality of life Oncology Cancer Research Quality of Life Research |
| ISBN | 3-030-23417-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | PREFACE -- I Epidemiology -- II Pathology and Biology -- 1 Pathology of brain metastases -- 2 Translationnal approaches -- 3 Molecular mechanisms driving brain metastases development -- 4 Genomics characterization of BM -- 5 BM cell partners and tumor microenvironment -- 6 Experimental models of Brain Metastases -- III Clinical presentation and symptom management -- 7 Clinical presentation -- 8 Epilepsy in CNS metastases -- 9 Safety, tolerability and use of steroids in CNS metastasis patients -- 10 Thrombo-embolic complications in BM patients -- IV Imaging -- 11 BM diagnosis and monitoring -- 12 Metabolic imaging of BM -- 13 Radiation necrosis and progression assessment and definition -- V Surgery -- 14 Modern surgical techniques -- 15 Quality of surgical resection assessment -- 16 Indications and emerging concepts in the era molecular biology -- VI Radiation Therapy -- 17 Stereotatic radiosurgery -- 18 WBRT -- 19 Combined radiation therapy and systemic treatment -- VII Systemic treatment -- 20 Lung -- 21 Breast.-. 22 Melanoma -- 23 Miscellaneous -- VIII Neurocognition and QoL -- IV Leptomeningeal disease -- X Prevention/Prohylaxis strategies -- XI Prognosis and prognostic models -- XII Clinical trials / Endpoints and outcome assessment. . |
| Record Nr. | UNINA-9910369935303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Central Nervous System Tumors / / Scott George Turner
| Central Nervous System Tumors / / Scott George Turner |
| Autore | Turner Scott George |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (276 pages) |
| Disciplina | 616.9948 |
| Soggetto topico | Central nervous system - Cancer |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910688273303321 |
Turner Scott George
|
||
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Central Nervous System Tumors : Primary and Secondary / / Feyzi Birol Sarica, editor
| Central Nervous System Tumors : Primary and Secondary / / Feyzi Birol Sarica, editor |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (264 pages) |
| Disciplina | 616.9948 |
| Soggetto topico | Central nervous system - Cancer |
| ISBN | 1-80356-753-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910678587803321 |
| London : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Central Nervous System Tumors / / edited by Scott George Turner
| Central Nervous System Tumors / / edited by Scott George Turner |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (112 pages) |
| Disciplina | 616.9948 |
| Soggetto topico | Central nervous system - Cancer |
| ISBN | 1-83969-307-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910586662803321 |
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnostic assessment and treatment of peripheral nerve tumors / / Fernando Guedes [and four others], editors
| Diagnostic assessment and treatment of peripheral nerve tumors / / Fernando Guedes [and four others], editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (380 pages) |
| Disciplina | 616.9948 |
| Soggetto topico |
Nerves, Peripheral - Tumors
Nervis perifèrics Tumors Diagnòstic Terapèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-77633-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910495157703321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - CNS and neurological disorders . Volume 4 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - CNS and neurological disorders . Volume 4 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Science Publishers, , [2016] |
| Descrizione fisica | 1 online resource (385 pages) |
| Disciplina | 616.9948 |
| Collana | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| Soggetto topico | Central nervous system |
| ISBN | 1-68108-295-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- CONTENTS -- PREFACE -- List of Contributors -- Multiple Sclerosis Drug Therapy: From the Classical Pharmaceutical Down to Cellular and Molecular Approach -- MULTIPLE SCLEROSIS -- Epidemiology, Environmental Agents and Genetics -- Pathogenesis -- Animal Models -- Different Immune System Players on the MS Stage -- T-cells -- B-cells -- Other Immune System Cells and the Innate Immune Response -- Histopathology -- Active Lesions -- Chronic Plaques -- Remyelinated Plaques -- Clinical Features and Diagnostic Criteria -- DISEASE-MODIFYING DRUGS -- Steroids -- Injectable Drugs -- Beta-Interferons -- Glatiramer Acetate -- Oral Drugs -- Teriflunomide -- Dimethyl Fumarate (DMF, BG-12) -- Fingolimod (FTY720) -- Conventional Immunosuppressants -- Cyclophosphamide -- Azathioprine -- Mitoxantrone -- Laquinimod -- Methotrexate -- Biologics (Monoclonal Antibodies) -- Natalizumab -- Alemtuzumab (Campath-1H) -- RECENT EMERGING BIOLOGICAL AND EXPERIMENTAL THERAPEUTICAL APPROACHES -- B-Cells -- Rituximab -- Ocrelizumab and Ofatumumab -- MEDI-551 -- Mast Cells -- Masitinib mesylate -- Cytokines and Chemokines -- Daclizumab -- Tabalumab (LY2127399) -- MOR103 -- Secukinumab -- Tolerogenic Vaccines for MS -- Stem Cells -- Haematopoietic Stem Cells (HSCs) -- Mesenchymal Stem Cells (MSCs) -- Helminths -- Vitamin D -- Remyelination Strategies in MS -- BIIB033 -- rHIgM22 -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- ABBREVIATIONS -- REFERENCES -- Prospective Therapies for Alzheimer Disease: Biomarkers, Clinical Trials and Preclinical Research -- I. INTRODUCTION -- I.1. Background -- I.2. Alzheimer's Disease and the Need for New Drugs -- I.3. The Amyloid Cascade Hypothesis (ACH) -- I.4. Correlation among Aβ and other AD Hallmarks -- I.5. Genetics of AD -- I.5.1. APP -- I.5.2. PSEN1/PSEN2 -- I.5.3. APOE -- I.5.4 . APOJ/CLU.
I.5.5. The Role of Genetic Testing in Clinical Care -- II. THE ROLE OF BIOMARKERS IN EARLY DIAGNOSIS AND CLINICAL TRIALS ASSESSMENT -- II.1. Biochemical Markers -- II.1.1. Cerebrospinal Fluid Biomarkers -- II.1.2. Blood Biomarkers -- II.2. Imaging-based Biomarkers -- II.2.1. Structural Magnetic Resonance Imaging -- II.2.2. Diffusion Tensor Imaging -- II.2.3. Functional Magnetic Resonance Imaging -- II.2.4. Proton Magnetic Resonance Spectroscopy -- II.2.5. Fluorodeoxyglucose-Positron Emission Tomography -- II.2.6. Amyloid-Positron Emission Tomography -- II.3. The Continuum of AD: Diagnosis and Prognosis -- II.4. Regulatory Framework -- III. PROSPECTIVE THERAPIES -- III.1. Non-immunologic Therapies -- III.1.1. Clinical Trials -- III.1.2. Preclinical Studies -- III.2. Immunotherapy -- III.2.1. Active Immunotherapy -- III.2.2. Passive Immunotherapy -- CONCLUSION AND FUTURE PERSPECTIVES -- CONFLICT OF INTEREST -- FUNDING -- ACKNOWLEDGMENTS -- REFERENCES -- At the Crossroad between Neuronal Hyperexcitability and Neuroinflammation: New Therapeutic Opportunities for Alzheimer's Disease? -- INTRODUCTION -- 1. BACKGROUND ON AD -- 1.1. APP Processing -- 1.2. Genetics of AD -- 1.3. Clinical Trials & -- Treatment Strategies -- 2. PRECLINICAL AVENUES -- 2.1. Neuroinflammation & -- Tumor Necrosis Factor-α -- 2.2. Network Hyperexcitability -- 3. CROSS-TALK BETWEEN SYNAPTIC HYPEREXCITABILITY & -- TNF -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- FUNDING -- REFERENCES -- Treatment of Diabetic Neuropathy - Current Possibilities and Perspectives -- INTRODUCTION -- DIABETES MELLITUS -- CHRONIC COMPLICATIONS OF DIABETES MELLITUS -- DIABETIC NEUROPATHY -- ETIOPATHOGENESIS OF DIABETIC NEUROPATHY -- Advanced Glycation End Products -- Oxidative Stress -- Gene Polymorphisms Of Antioxidant Enzymes And Chronic Diabetic Complications. Polyol Pathway -- Protein Kinase C -- Hexosamine Pathway -- Low C-peptide Concentration -- Proinflammatory Cytokines -- Neurotrophic Factors -- Angiotensin-converting Enzyme -- Kinin B1 Receptor -- TREATMENT OF DIABETIC NEUROPATHY -- Treatment of Diabetes Mellitus - Adequate Compensation -- Supportive and Additional Treatment -- Alpha-lipoic Acid -- Symptomatic Treatment -- Treatment in Experimental and Clinical Studies -- Anti-inflammatory Drugs -- Neurotrophic Factors -- Angiotensin Converting enzyme (ACE) Inhibitors -- Novel Drugs with Antioxidant Functions -- Non-pharmacological Therapy -- inhibitors of Epigenetic Modifications -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- The Now and Tomorrow of Migraine Treatments -- INTRODUCTION -- PATHOPHYSIOLOGICAL OVERVIEW -- ACUTE ATTACK TREATMENT -- Currently Available Drugs -- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) -- Ergot Alkaloids and Triptans -- Combination Regimens -- Narcotic Analgesics -- Hyperbaric Oxygen Therapy -- Medication Overuse Headache -- Novel Targets for Attack Treatment -- CGRP -- NOS Inhibition -- TRP Channels -- Glutamate Receptors -- PACAP-38 -- Cannabinoids -- The Parenchymal Inflammatory Cascade -- PROPHYLACTIC TREATMENT -- Currently Available Drugs -- Antiepileptics -- Antidepressants -- Beta Blockers -- Calcium Channel Blockers -- Glutamate Receptor Antagonists -- Triptans -- Novel Targets for Prophylactic Treatment -- CGRP -- NOS Inhibition -- Gap Junction Blockers -- Renin-Angiotensin System -- Acid Sensing Ion Channels -- Botulinum Neurotoxin -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- The Now and Tomorrow of Ischemic Stroke Treatment -- ADVANCES IN TREATMENT OF ACUTE ISCHEMIC STROKE -- Recanalization/Reperfusion -- Neuro-Glial Protection -- Prevention of Secondary Complications. ADVANCES IN SECONDARY PROPHYLAXIS OF ISCHEMIC STROKE -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- SUBJECT INDEX. |
| Record Nr. | UNINA-9910798302603321 |
| Sharjah, United Arab Emirates : , : Bentham Science Publishers, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in clinical drug research - CNS and neurological disorders . Volume 4 / / edited by Atta-ur-Rahman
| Frontiers in clinical drug research - CNS and neurological disorders . Volume 4 / / edited by Atta-ur-Rahman |
| Pubbl/distr/stampa | Sharjah, United Arab Emirates : , : Bentham Science Publishers, , [2016] |
| Descrizione fisica | 1 online resource (385 pages) |
| Disciplina | 616.9948 |
| Collana | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| Soggetto topico | Central nervous system |
| ISBN | 1-68108-295-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- CONTENTS -- PREFACE -- List of Contributors -- Multiple Sclerosis Drug Therapy: From the Classical Pharmaceutical Down to Cellular and Molecular Approach -- MULTIPLE SCLEROSIS -- Epidemiology, Environmental Agents and Genetics -- Pathogenesis -- Animal Models -- Different Immune System Players on the MS Stage -- T-cells -- B-cells -- Other Immune System Cells and the Innate Immune Response -- Histopathology -- Active Lesions -- Chronic Plaques -- Remyelinated Plaques -- Clinical Features and Diagnostic Criteria -- DISEASE-MODIFYING DRUGS -- Steroids -- Injectable Drugs -- Beta-Interferons -- Glatiramer Acetate -- Oral Drugs -- Teriflunomide -- Dimethyl Fumarate (DMF, BG-12) -- Fingolimod (FTY720) -- Conventional Immunosuppressants -- Cyclophosphamide -- Azathioprine -- Mitoxantrone -- Laquinimod -- Methotrexate -- Biologics (Monoclonal Antibodies) -- Natalizumab -- Alemtuzumab (Campath-1H) -- RECENT EMERGING BIOLOGICAL AND EXPERIMENTAL THERAPEUTICAL APPROACHES -- B-Cells -- Rituximab -- Ocrelizumab and Ofatumumab -- MEDI-551 -- Mast Cells -- Masitinib mesylate -- Cytokines and Chemokines -- Daclizumab -- Tabalumab (LY2127399) -- MOR103 -- Secukinumab -- Tolerogenic Vaccines for MS -- Stem Cells -- Haematopoietic Stem Cells (HSCs) -- Mesenchymal Stem Cells (MSCs) -- Helminths -- Vitamin D -- Remyelination Strategies in MS -- BIIB033 -- rHIgM22 -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- ABBREVIATIONS -- REFERENCES -- Prospective Therapies for Alzheimer Disease: Biomarkers, Clinical Trials and Preclinical Research -- I. INTRODUCTION -- I.1. Background -- I.2. Alzheimer's Disease and the Need for New Drugs -- I.3. The Amyloid Cascade Hypothesis (ACH) -- I.4. Correlation among Aβ and other AD Hallmarks -- I.5. Genetics of AD -- I.5.1. APP -- I.5.2. PSEN1/PSEN2 -- I.5.3. APOE -- I.5.4 . APOJ/CLU.
I.5.5. The Role of Genetic Testing in Clinical Care -- II. THE ROLE OF BIOMARKERS IN EARLY DIAGNOSIS AND CLINICAL TRIALS ASSESSMENT -- II.1. Biochemical Markers -- II.1.1. Cerebrospinal Fluid Biomarkers -- II.1.2. Blood Biomarkers -- II.2. Imaging-based Biomarkers -- II.2.1. Structural Magnetic Resonance Imaging -- II.2.2. Diffusion Tensor Imaging -- II.2.3. Functional Magnetic Resonance Imaging -- II.2.4. Proton Magnetic Resonance Spectroscopy -- II.2.5. Fluorodeoxyglucose-Positron Emission Tomography -- II.2.6. Amyloid-Positron Emission Tomography -- II.3. The Continuum of AD: Diagnosis and Prognosis -- II.4. Regulatory Framework -- III. PROSPECTIVE THERAPIES -- III.1. Non-immunologic Therapies -- III.1.1. Clinical Trials -- III.1.2. Preclinical Studies -- III.2. Immunotherapy -- III.2.1. Active Immunotherapy -- III.2.2. Passive Immunotherapy -- CONCLUSION AND FUTURE PERSPECTIVES -- CONFLICT OF INTEREST -- FUNDING -- ACKNOWLEDGMENTS -- REFERENCES -- At the Crossroad between Neuronal Hyperexcitability and Neuroinflammation: New Therapeutic Opportunities for Alzheimer's Disease? -- INTRODUCTION -- 1. BACKGROUND ON AD -- 1.1. APP Processing -- 1.2. Genetics of AD -- 1.3. Clinical Trials & -- Treatment Strategies -- 2. PRECLINICAL AVENUES -- 2.1. Neuroinflammation & -- Tumor Necrosis Factor-α -- 2.2. Network Hyperexcitability -- 3. CROSS-TALK BETWEEN SYNAPTIC HYPEREXCITABILITY & -- TNF -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- FUNDING -- REFERENCES -- Treatment of Diabetic Neuropathy - Current Possibilities and Perspectives -- INTRODUCTION -- DIABETES MELLITUS -- CHRONIC COMPLICATIONS OF DIABETES MELLITUS -- DIABETIC NEUROPATHY -- ETIOPATHOGENESIS OF DIABETIC NEUROPATHY -- Advanced Glycation End Products -- Oxidative Stress -- Gene Polymorphisms Of Antioxidant Enzymes And Chronic Diabetic Complications. Polyol Pathway -- Protein Kinase C -- Hexosamine Pathway -- Low C-peptide Concentration -- Proinflammatory Cytokines -- Neurotrophic Factors -- Angiotensin-converting Enzyme -- Kinin B1 Receptor -- TREATMENT OF DIABETIC NEUROPATHY -- Treatment of Diabetes Mellitus - Adequate Compensation -- Supportive and Additional Treatment -- Alpha-lipoic Acid -- Symptomatic Treatment -- Treatment in Experimental and Clinical Studies -- Anti-inflammatory Drugs -- Neurotrophic Factors -- Angiotensin Converting enzyme (ACE) Inhibitors -- Novel Drugs with Antioxidant Functions -- Non-pharmacological Therapy -- inhibitors of Epigenetic Modifications -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- The Now and Tomorrow of Migraine Treatments -- INTRODUCTION -- PATHOPHYSIOLOGICAL OVERVIEW -- ACUTE ATTACK TREATMENT -- Currently Available Drugs -- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) -- Ergot Alkaloids and Triptans -- Combination Regimens -- Narcotic Analgesics -- Hyperbaric Oxygen Therapy -- Medication Overuse Headache -- Novel Targets for Attack Treatment -- CGRP -- NOS Inhibition -- TRP Channels -- Glutamate Receptors -- PACAP-38 -- Cannabinoids -- The Parenchymal Inflammatory Cascade -- PROPHYLACTIC TREATMENT -- Currently Available Drugs -- Antiepileptics -- Antidepressants -- Beta Blockers -- Calcium Channel Blockers -- Glutamate Receptor Antagonists -- Triptans -- Novel Targets for Prophylactic Treatment -- CGRP -- NOS Inhibition -- Gap Junction Blockers -- Renin-Angiotensin System -- Acid Sensing Ion Channels -- Botulinum Neurotoxin -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- The Now and Tomorrow of Ischemic Stroke Treatment -- ADVANCES IN TREATMENT OF ACUTE ISCHEMIC STROKE -- Recanalization/Reperfusion -- Neuro-Glial Protection -- Prevention of Secondary Complications. ADVANCES IN SECONDARY PROPHYLAXIS OF ISCHEMIC STROKE -- CONCLUDING REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- SUBJECT INDEX. |
| Record Nr. | UNINA-9910808718803321 |
| Sharjah, United Arab Emirates : , : Bentham Science Publishers, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Glioblastoma / / edited by Steven De Vleeschouwer
| Glioblastoma / / edited by Steven De Vleeschouwer |
| Pubbl/distr/stampa | Brisbane : , : Exon Publications, , 2017 |
| Descrizione fisica | 1 online resource (xx, 432 pages) : illustrations |
| Disciplina | 616.9948 |
| Soggetto topico | Glioblastoma multiforme |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910569199103321 |
| Brisbane : , : Exon Publications, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Intracranial and Spinal Radiotherapy : A Practical Guide on Treatment Techniques / / edited by Lia M. Halasz, Simon S. Lo, Eric L. Chang, Arjun Sahgal
| Intracranial and Spinal Radiotherapy : A Practical Guide on Treatment Techniques / / edited by Lia M. Halasz, Simon S. Lo, Eric L. Chang, Arjun Sahgal |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (XII, 211 p. 93 illus., 83 illus. in color.) |
| Disciplina | 616.9948 |
| Collana | Practical Guides in Radiation Oncology |
| Soggetto topico |
Radiology
Medical physics Internal medicine Neurology Medical Physics Internal Medicine Radioteràpia Tumors cerebrals Columna vertebral Tumors |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-64508-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Arteriovenous Malformation -- Benign Meningioma -- Atypical and Malignant Meningioma -- Craniopharyngioma -- Paraganglioma -- Pituitary adenoma -- Vestibular Schwannoma -- Hemangiopericytoma -- Chordoma and Chondrosarcoma -- Ganglioglioma -- Ependymoma -- Adult Pilocytic Astrocytoma -- Pleomorphic Xanthroastrocytoma (PXA) -- WHO Grade II and III Glioma -- Glioblastoma -- Brainstem Glioma -- Pineal Tumors (PPTID, PTPR) -- Adult Medulloblastoma -- Intracranial Germ Cell Tumors -- Brain Metastases: Intact and Postoperative Radiosurgery -- Brain Metastases: Whole brain radiation therapy -- Primary Spinal Cord Tumors -- Spinal Metastases -- Management of acute side effects of brain irradiation (besides radionecrosis) -- Radiation Necrosis: A Practical Approach -- Management of spine SBRT adverse effects -- Monitoring and management of late effects. |
| Record Nr. | UNINA-9910483911403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
